135 related articles for article (PubMed ID: 6189346)
1. Keratodermia punctata hereditaria treated with etretinate (Tigason).
Christiansen JV
Acta Derm Venereol; 1983; 63(2):181. PubMed ID: 6189346
[No Abstract] [Full Text] [Related]
2. Etretinate in treatment of actinic keratosis. A double-blind crossover study.
Moriarty M; Dunn J; Darragh A; Lambe R; Brick I
Lancet; 1982 Feb; 1(8268):364-5. PubMed ID: 6120350
[TBL] [Abstract][Full Text] [Related]
3. [Etretinat (Tigason). A vitamin A acid derivative for peroral treatment of hyperkeratotic dermatoses].
Foged EK; Laurberg G; Schmidt H
Ugeskr Laeger; 1983 Jun; 145(23):1797-9. PubMed ID: 6879814
[No Abstract] [Full Text] [Related]
4. Severe disorders of keratinization: effects of treatment with Tigason (etretinate).
Marks R; Finlay AY; Holt PJ
Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177
[TBL] [Abstract][Full Text] [Related]
5. [Results of treatment of a number of disorders in the keratinization of the skin using an aromatic retinoid (Ro 10-9359)].
Notowicz A; Vermeiden I; Stolz E
Ned Tijdschr Geneeskd; 1980 Aug; 124(31):1286-90. PubMed ID: 7412901
[No Abstract] [Full Text] [Related]
6. Keratodermia palmoplantare papuloverrucoides progressiva: successful treatment with etretinate.
Baran R; Juhlin L
J Am Acad Dermatol; 1983 May; 8(5):700-2. PubMed ID: 6223052
[TBL] [Abstract][Full Text] [Related]
7. Retinoid acid in the treatment of hyperkeratosis lenticularis perstans Flegel.
Lindemayr H; Jurecka W
Acta Derm Venereol; 1982; 62(1):89-91. PubMed ID: 6175154
[No Abstract] [Full Text] [Related]
8. [A case of erythrokeratodermia figurata variabilis successfully treated with tigason].
Magyarlaki M; Drobnitsch I; Zombai E; Schneider I
Z Hautkr; 1989 Oct; 64(10):881-2, 885-7. PubMed ID: 2531508
[TBL] [Abstract][Full Text] [Related]
9. [Tigason in hyperkeratosis lenticularis perstans (HLP)--a case report].
Gabrielsen TO
Z Hautkr; 1986 Feb; 61(4):214-7. PubMed ID: 3962407
[TBL] [Abstract][Full Text] [Related]
10. [A case of mycosis fungoides with tumoral manifestations, treated with RO 10-9359 (Tigáson)].
Ippolito F; Giacalone B
Ann Dermatol Venereol; 1982; 109(1):65-72. PubMed ID: 7073187
[No Abstract] [Full Text] [Related]
11. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
Findlay GH
S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876
[TBL] [Abstract][Full Text] [Related]
12. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
Jagell S; Lidén S
Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and histological studies of the effect of an aromatic retinoid Ro 10-9359 on a syndrome related to Bazex paraneoplastic acrokeratosis].
Le T; Pierard GE
Dermatologica; 1982; 165(6):559-67. PubMed ID: 7169131
[No Abstract] [Full Text] [Related]
14. Treatment of disseminated superficial actinic porokeratosis with a new aromatic retinoid (Ro 10-9359).
Kariniemi AL; Stubb S; Lassus A
Br J Dermatol; 1980 Feb; 102(2):213-4. PubMed ID: 7387874
[No Abstract] [Full Text] [Related]
15. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
[TBL] [Abstract][Full Text] [Related]
16. Biochemical changes after the oral administration of retinoid in the horny layer of patients with keratinization disorders.
Yoshiike T; Negi M; Manabe M; Takamori K; Ogawa H
J Dermatol; 1982 Jun; 9(3):235-42. PubMed ID: 6752237
[No Abstract] [Full Text] [Related]
17. Etretinate (Tigason) for skin disease.
Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967
[No Abstract] [Full Text] [Related]
18. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial.
Alfthan O; Tarkkanen J; Gröhn P; Heinonen E; Pyrhönen S; Säilä K
Eur Urol; 1983; 9(1):6-9. PubMed ID: 6337054
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
Pehamberger H; Esca SA; Holubar K
Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
[TBL] [Abstract][Full Text] [Related]
20. [A case of superficial disseminated actinic porokeratosis treated with an aromatic retinoid].
Ludera-Zimoch G; Rubisz-Brzezińska J
Przegl Dermatol; 1989; 76(1):54-7. PubMed ID: 2813819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
